Previous close | 14.85 |
Open | 14.81 |
Bid | 14.72 x 300 |
Ask | 14.79 x 700 |
Day's range | 14.65 - 14.90 |
52-week range | 14.65 - 33.99 |
Volume | |
Avg. volume | 1,894,012 |
Market cap | 2.444B |
Beta (5Y monthly) | 0.42 |
PE ratio (TTM) | ∞ |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
It's been a mediocre week for ACADIA Pharmaceuticals Inc. ( NASDAQ:ACAD ) shareholders, with the stock dropping 11% to...
ACADIA's Revenue Surges with Strong Sales from NUPLAZID and DAYBUE
ACADIA Pharmaceuticals ( NASDAQ:ACAD ) First Quarter 2024 Results Key Financial Results Revenue: US$205.8m (up 74% from...